Success Metrics

Active Trials

2(67%)

Phase Distribution

Ph phase_3

33%

Ph phase_2

33%

Ph not_applicable

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

1(33.3%)

Phase 3Large-scale testing

1(33.3%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Detailed Status

Active, not recruiting1

Recruiting1

Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 3

Trials by Phase

Phase 21 (33.3%)

Phase 31 (33.3%)

N/A1 (33.3%)

Trials by Status

active_not_recruiting133%

recruiting133%

enrolling_by_invitation133%

Recent Activity

2 active trials

Showing 3 of 3

enrolling_by_invitationnot_applicable

AIM-WEIGHT: AI-Guided Microbiome-Targeted Nutritional Intervention for Weight Loss

NCT07736547

active_not_recruitingphase_2

Effect of PXS-4728A on Microglia Activation in Participants With Isolated Rapid Eye Movement Sleep Behaviour Disorder

NCT05904717

recruitingphase_3

The SELEQT-HF (SELEnium and CoQ10 NuTrition for Heart Failure) Study Will Evaluate the Effect of Adding Selenium/and coQ10 on Top of Standard HF Therapy in Patients With HF and Will do so Using a Pragmatic, Registry Based Randomized Controlled Trial in the Netherlands.

NCT07234422

Clinical Trials (3)

Showing 3 of 3 trials

NCT07736547Not Applicable

AIM-WEIGHT: AI-Guided Microbiome-Targeted Nutritional Intervention for Weight Loss

Enrolling By Invitation

NCT05904717Phase 2

Effect of PXS-4728A on Microglia Activation in Participants With Isolated Rapid Eye Movement Sleep Behaviour Disorder

Active Not Recruiting

NCT07234422Phase 3

The SELEQT-HF (SELEnium and CoQ10 NuTrition for Heart Failure) Study Will Evaluate the Effect of Adding Selenium/and coQ10 on Top of Standard HF Therapy in Patients With HF and Will do so Using a Pragmatic, Registry Based Randomized Controlled Trial in the Netherlands.

Recruiting

All 3 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 3